melagatran has been researched along with Chronic Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cau, J; Favreau, F; Hauet, T; Lerman, LO; Manguy, E; Mauco, G; Milin, S; Thuillier, R; Zhu, X | 1 |
| Attman, PO; Eriksson, UG; Eriksson-Lepkowska, M; Fager, G; Ottosson, P; Samuelsson, O | 1 |
| Attman, PO | 1 |
1 trial(s) available for melagatran and Chronic Disease
| Article | Year |
|---|---|
Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia.
Topics: Adult; Aged; Anticoagulants; Antithrombins; Azetidines; Benzylamines; Chronic Disease; Dalteparin; Glycine; Humans; International Normalized Ratio; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Uremia | 2005 |
2 other study(ies) available for melagatran and Chronic Disease
| Article | Year |
|---|---|
Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model.
Topics: Adenosine; Allopurinol; Animals; Anticoagulants; Azetidines; Base Sequence; Benzylamines; Chronic Disease; DNA Primers; Fibrosis; Glutathione; Humans; Insulin; Kidney; Kidney Transplantation; Male; Models, Animal; Organ Preservation; Organ Preservation Solutions; Oxidative Stress; Plasminogen Activator Inhibitor 1; Raffinose; RNA, Messenger; Signal Transduction; Swine; Temperature; Tissue Donors; Tissue Plasminogen Activator; Transforming Growth Factor beta; Transplantation, Autologous | 2010 |
Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia.
Topics: Anticoagulants; Azetidines; Benzylamines; Chronic Disease; Humans; Renal Dialysis; Thrombin; Thrombosis; Uremia | 2006 |